Arzu Nazlı

719 total citations
27 papers, 392 citations indexed

About

Arzu Nazlı is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Arzu Nazlı has authored 27 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 11 papers in Epidemiology and 4 papers in Virology. Recurrent topics in Arzu Nazlı's work include HIV/AIDS Research and Interventions (6 papers), HIV, Drug Use, Sexual Risk (5 papers) and HIV Research and Treatment (4 papers). Arzu Nazlı is often cited by papers focused on HIV/AIDS Research and Interventions (6 papers), HIV, Drug Use, Sexual Risk (5 papers) and HIV Research and Treatment (4 papers). Arzu Nazlı collaborates with scholars based in Türkiye, United Kingdom and Croatia. Arzu Nazlı's co-authors include Sezai Taşbakan, Cengiz Çavuşoğlu, Oğuz Reşat Sıpahı, Patrice Nordmann, Bilgin Arda, Encho Savov, Laurent Poirel, Ива Тодорова, Vildan Avkan-Oğuz and Meltem Taşbakan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Arzu Nazlı

22 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arzu Nazlı Türkiye 8 284 241 149 48 28 27 392
Mubin Kazi India 10 299 1.1× 255 1.1× 136 0.9× 123 2.6× 51 1.8× 19 442
Murat Sütçü Türkiye 11 132 0.5× 168 0.7× 52 0.3× 56 1.2× 29 1.0× 58 352
J. D. García-Palomo Spain 9 286 1.0× 316 1.3× 98 0.7× 22 0.5× 47 1.7× 14 477
Glen Huang United States 11 205 0.7× 123 0.5× 53 0.4× 27 0.6× 14 0.5× 25 379
Hilte Geerdes‐Fenge Germany 10 171 0.6× 157 0.7× 54 0.4× 33 0.7× 30 1.1× 43 329
Reihaneh Hosseinpour Sadeghi Iran 11 165 0.6× 96 0.4× 67 0.4× 65 1.4× 76 2.7× 43 321
Viral Vadwai India 10 469 1.7× 375 1.6× 343 2.3× 79 1.6× 34 1.2× 17 625
Chin-Shiang Tsai Taiwan 11 177 0.6× 112 0.5× 33 0.2× 31 0.6× 15 0.5× 32 316
I. Mohammédi France 11 205 0.7× 99 0.4× 66 0.4× 17 0.4× 33 1.2× 32 372
Teresa Vicente Spain 6 219 0.8× 233 1.0× 221 1.5× 40 0.8× 19 0.7× 17 462

Countries citing papers authored by Arzu Nazlı

Since Specialization
Citations

This map shows the geographic impact of Arzu Nazlı's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arzu Nazlı with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arzu Nazlı more than expected).

Fields of papers citing papers by Arzu Nazlı

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arzu Nazlı. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arzu Nazlı. The network helps show where Arzu Nazlı may publish in the future.

Co-authorship network of co-authors of Arzu Nazlı

This figure shows the co-authorship network connecting the top 25 collaborators of Arzu Nazlı. A scholar is included among the top collaborators of Arzu Nazlı based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arzu Nazlı. Arzu Nazlı is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Turan, Bülent, Arzu Nazlı, Hamed Abdollahpour Ranjbar, et al.. (2025). HIV-related microaggressions and depressive symptoms among people living with HIV: the mediating roles of internalised stigma and coping with shame. Sexually Transmitted Infections. 101(6). 380–385. 1 indexed citations
2.
Nazlı, Arzu, et al.. (2024). Impact of the COVID-19 Pandemic on People Newly Diagnosed with HIV and those Already in -care in Türkiye. Current HIV Research. 22(5). 290–297.
3.
Ayhan, Zi̇ya, et al.. (2024). Endogenous Endophthalmitis Caused by Aspergillus lentulus in an Immunocompromised Patient with Lung Cancer. Turkish Journal of Ophthalmology. 54(3). 175–179. 1 indexed citations
4.
Nazlı, Arzu, et al.. (2024). The Performance of the Current Algorithm of HIV Diagnosis. Iranian Journal of Public Health. 53(7). 1569–1577. 1 indexed citations
5.
Nazlı, Arzu, et al.. (2023). Never forget ocular syphilis: A case series from a single tertiary centre. International Journal of STD & AIDS. 34(11). 817–822. 2 indexed citations
6.
Nazlı, Arzu, et al.. (2022). Aile Hekimleri ve Tıp Fakültesi Öğrencileri Kronik Hepatit C İnfeksiyonunun Farkında Mı?. AYBU AVESIS. 27(3). 493–503. 1 indexed citations
7.
Avkan-Oğuz, Vildan, et al.. (2022). Fungal colonization and infections in patients with COVID-19 in intensive care units: A real-life experience at a tertiary-care hospital. Respiratory Medicine and Research. 82. 100937–100937. 13 indexed citations
8.
Avkan-Oğuz, Vildan, et al.. (2022). The Effect of the Pandemic on Antifungal Use: What Has Changed?. PubMed. 4(3). 156–162. 1 indexed citations
9.
Nazlı, Arzu, et al.. (2022). Evaluation of SARS-CoV-2 antibody persistence and viral spread in stool: a long-term care experience before COVID-19 vaccination. Irish Journal of Medical Science (1971 -). 192(1). 263–268. 1 indexed citations
10.
Şimşek, Hatice, et al.. (2021). Epidemiological Characteristics of COVID-19 Cases in A University Hospital in Turkey. Klimik Dergisi/Klimik Journal. 34(1). 61–68. 3 indexed citations
11.
Nazlı, Arzu, et al.. (2021). Evaluation of Correlation Between Anxiety and COVID-19 Knowledge Among Healthcare Workers. 35(50). 259–265. 2 indexed citations
12.
Ünal, Belgin, Arzu Nazlı, Oğuz Kılınç, et al.. (2021). OOOOO Hospital COVID-19 Follow-up Center: Performance and Preliminary Findings. 35(3). 0–0.
13.
Nazlı, Arzu, Aylin Özgen Alpaydın, Başak Bayram, et al.. (2021). Hafif Seyirli COVID-19 Hastalarının İnfeksiyondan Altı Ay Sonraki Mortalite ve Reinfeksiyon Oranları. SHILAP Revista de lepidopterología. 26(2). 267–276. 1 indexed citations
14.
Nazlı, Arzu, Bilgin Arda, Oğuz Reşat Sıpahı, & Mehmet Uyar. (2020). Factors Related to Mortality in Carbapenem Resistant Acinetobacter baumannii Infections in Intensive Care Units: A Prospective Observational Study. SHILAP Revista de lepidopterología. 25(3). 391–400.
15.
Nazlı, Arzu, et al.. (2018). Serratia marcescens sepsis outbreak caused by contaminated propofol. American Journal of Infection Control. 47(5). 582–584. 13 indexed citations
16.
Sıpahı, Oğuz Reşat, Arzu Nazlı, Meltem Taşbakan, et al.. (2017). Pooled analysis of 899 nosocomial meningitis episodes from Turkey. TURKISH JOURNAL OF MEDICAL SCIENCES. 47(1). 29–33. 13 indexed citations
18.
Poirel, Laurent, et al.. (2014). Outbreak Caused by NDM-1- and RmtB-Producing Escherichia coli in Bulgaria. Antimicrobial Agents and Chemotherapy. 58(4). 2472–2474. 34 indexed citations
19.
Nazlı, Arzu, Meltem Taşbakan, Hüsnü Pullukçu, et al.. (2013). Evaluation of Zygomycosis Cases by Pooled Analysis Method Reported from Turkey. Mikrobiyoloji Bulteni. 47(4). 708–716. 8 indexed citations
20.
Nazlı, Arzu, Sezai Taşbakan, & Cengiz Çavuşoğlu. (2011). Evaluation of the GeneXpert MTB/RIF Assay for Rapid Diagnosis of Tuberculosis and Detection of Rifampin Resistance in Pulmonary and Extrapulmonary Specimens. Journal of Clinical Microbiology. 49(12). 4138–4141. 259 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026